乙CoA结合蛋白 (ACBP):一种自检查点,可以向改善癌症免疫监测
Léa Montégut1,2, Isabelle Martins1,2, Guido Kroemer1,3
1Team Metabolism, Cancer and Immunity, Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.
Oncoimmunology
|October 9, 2024
概括
乙CoA结合蛋白 (ACBP) 限制了自,并作为细胞外检查点. 用抗体中和ACBP增强了癌症免疫监测,并改善了临床前化疗免疫疗法模型的结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 由DB I基因编码的Acyl CoA结合蛋白 (ACBP) 作为组织激素起作用.
- ACBP充当细胞外检查点,限制各种细胞类型的自.
- 之前的研究表明,ACBP中和可增强乳腺和肺癌的免疫监测.
研究的目的:
- 研究ACBP中和在癌症中的治疗潜力.
- 评估ACBP封锁对免疫监测和化疗免疫治疗结果的影响.
主要方法:
- 使用单克隆抗体中和ACBP活动.
- 评估自水平的变化和癌细胞免疫监测.
- 在乳腺和肺癌的临床前模型中评估治疗结果,这些模型正在接受PD-1阻断的新辅助化疗免疫疗法.
主要成果:
- 证明ACBP中和可以改善癌症免疫监测.
- 在临床前情况下,ACBP的中和增强了新辅助化学免疫疗法与PD-1阻断相结合的疗效.
- 在经过测试的癌瘤模型中,ACBP阻塞对治疗结果产生了积极的影响.
结论:
- ACBP是自的关键调节剂,也是癌症免疫治疗的潜在目标.
- 通过抗体中介的ACBP中和是一种增强抗瘤免疫力的有希望的策略.
- 针对ACBP可能会提高当前癌症治疗方法的有效性,包括化疗免疫疗法.
相关概念视频
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K


